CYSB1900326 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2019-09-19 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2019-12-13 | view |
CXSB1400017 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2014-12-26 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2016-10-11 | view |
CYSB1300123 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products | Supplementary Application | 2013-06-03 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2014-01-03 | view |
CXSS0700068 | 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2007-12-07 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2011-04-14 | view |
CXSL0500003 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2005-02-22 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2005-11-23 | view |
X0304086 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2004-03-17 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2004-06-23 | view |
X0400429 | 注射用重组人II型肿瘤坏死因子受体-抗体融合蛋白 | | Lyophilized | Biological Products(7) | New Drug Application | 2004-02-04 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2004-08-30 | view |
X0306108 | 注射用重组人甲状旁腺激素(1-34) | parathyroid hormone | Lyophilized | Biological Products(7) | New Drug Application | 2003-12-10 | 上海赛金生物医药有限公司 | Shanghai Celgen Bio-Pharmaceutical Co Ltd | Certificate Issued | 2004-09-10 | view |